PFENEX
Headquartered in San Diego, California, Pfēnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfēnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfēnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.
PFENEX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-12-07
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.pfenex.com
Total Employee:
11+
Status:
Active
Contact:
18583524339
Total Funding:
63.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS COVID-19 CloudFront
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Board_member
Current Employees Featured
Patrick Lucy VP Business Development @ Pfenex
VP Business Development
Henry Talbot VP Research and Operations @ Pfenex
VP Research and Operations
James C. Gale Director @ Pfenex
Director
Albert Hansen Director @ Pfenex
Director
Dennis Merens Director @ Pfenex
Director
Stock Details
Investors List
Signet Healthcare Partners
Signet Healthcare Partners investment in Series A - Pfenex
The Dow Chemical Company
The Dow Chemical Company investment in Series A - Pfenex
Newest Events participated
Participated in Viral Safety 2017
on 2017-04-25 as exhibitor
Official Site Inspections
http://www.pfenex.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Pfenex"
Pfenex - Crunchbase Company Profile & Funding
A carrier protein produced using Pfenex Expression Technology, used in vaccines and therapeutics for enhancing antigen immunogenicity. Function Generator A …See details»
Manufacturing Solutions for Biotherapeutics and Vaccines
Jan 10, 2025 Pfenex Expression Technology® for Complex Protein Expression. Our flagship protein production platform, based on Pseudomonas fluorescens, has been widely adopted …See details»
Pfenex Inc. Company Profile | San Diego, CA - Dun & Bradstreet
The company's lead candidates are PF708, which mimics osteoporosis treatment Eli Lilly's Forteo and novel anthrax vaccine candidates Px563L and RPA563. Pfenex was formed in 2009 as a …See details»
Pfenex - VentureRadar
Pfenex Inc. existed as a privately held biotechnology company from 2009 until our initial public offering in 2015. When Pfenex spun out of Dow, we were assigned the entire intellectual …See details»
Ligand to Acquire Pfenex Inc. - Business Wire
Aug 10, 2020 Contacts. Ligand Pharmaceuticals Incorporated Patrick O’Brien investors@ligand.com (858) 550-7893 Twitter: @Ligand_LGND LHA Investor Relations Bruce …See details»
Pfenex Company Profile & Introduction - Tiger Brokers
Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include …See details»
EIN 27-1356759 - Pfenex Inc., San Diego, California - EIN TaxId
Pfenex Inc. is a corporation in San Diego, California. The employer identification number (EIN) for Pfenex Inc. is 271356759. EIN for organizations is sometimes also referred to as taxpayer …See details»
Pfenex - Funding, Financials, Valuation & Investors - Crunchbase
Pfenex is registered under the ticker NYSE:PFNX . Their stock opened with $15.50 in its Jul 18, 2014 IPO. Pfenex is funded by 2 investors. Signet Healthcare Partners and Dow are the most …See details»
Pfenex - Contacts, Employees, Board Members, Advisors & Alumni …
Organization. Pfenex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Organization | Pfenex, Inc
Pfenex, Inc Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: San Diego CA United States (2009 ... Organization Overview. First Clinical Trial. 2013 NCT02121353. First …See details»
About Pfenex Inc (PFNX) - Investing.com
Pfenex Inc. was incorporated in 2009 and is headquartered in San Diego, California. As of September 29, 2020, Pfenex Inc. operates as a subsidiary of Ligand Pharmaceuticals …See details»
Ligand Pharmaceuticals agrees to acquire Pfenex for $516m
Aug 11, 2020 Ligand Pharmaceuticals has entered into a definitive agreement to acquire development and licencing biotechnology firm Pfenex in a deal valued at approximately …See details»
Driving improvements from Discovery to Approval - Primrose Bio
As a fully integrated CMC organization, we’re suited to ensure your success. Arcellx, Inc. and Pfenex entered into a Development, Evaluation and License agreement in 2018 under which …See details»
Pfenex Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Pfenex. See Pfenex company profile and funding data.See details»
Ligand Completes Acquisition of Pfenex Inc. - Business Wire
Oct 1, 2020 Pfenex is now a wholly owned subsidiary of Ligand. The tender offer for all of the outstanding shares of common stock of Pfenex at a price of $12.00 per share, in cash, plus a …See details»
Pfenex Inc. (PFNX) 10K Annual Reports & 10Q SEC Filings
Mar 11, 2020 — Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to develop …See details»
Pfenex | Scientist.com
Pfenex 10790 Roselle St San Diego, CA, 92121 United States: Get started If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If …See details»
Serum Institute of India Private Limited has achieved World Health ...
SAN DIEGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that Serum Institute of India Private Limited (Serum Institute) achieved World …See details»
Ranibizumab biosimilar - Primrose Bio - AdisInsight - Springer
01 Oct 2020 Pfenex has been acquired by Ligand Pharmaceuticals 07 Jun 2019 Ranibizumab biosimilar - Pfenex is available for licensing as of 01 Nov 2017. https: //www ... If your …See details»
Ranibizumab biosimilar - Primrose Bio - AdisInsight
01 Oct 2020 Pfenex has been acquired by Ligand Pharmaceuticals 07 Jun 2019 Ranibizumab biosimilar - Pfenex is available for licensing as of 01 Nov 2017. https: //www ... If your …See details»